Adam Gefvert is the head researcher for White Diamond Research, a research firm for hedge funds and high net worth individuals. Primarily a short seller, he has saved investors millions of dollars by exposing highly overvalued small cap stocks. He has a 90%+ success rate with his Seeking Alpha short ideas. He specializes in technology, energy, and biotech stocks, because those are the sectors with the greatest valuation inefficiencies.
You can follow Adam on twitter @shiningboy
"If in an unknowable world, none of your bridges fall down, you are building them too strong. Similarly, if in an unknowable world none of your investment looks foolish after the fact, you are staying too far away from the unknowable."
-Richard Zeckhauser, "Investing in the Unknown and Unknowable"
Mr. Cutler's background includes 15 years of energy trading and risk management systems consulting to commodity trading shops, investment banks, power, natural gas and oil companies throughout North America. Former clients include JP Morgan, Shell, Bear Stearns, ExxonMobil, BP, PacifiCorp (owned by Berkshire Hathaway), Calpine and Williams. He was a partner at The Structure Group, a premier energy consulting firm, prior to Structure being acquired by Accenture, where he began his career. Mr. Cutler currently manages a small (two partners) investment fund, Stratesis, LLC, utilizing internally developed algorithms leveraging a big data approach.
He holds a Bachelor of Science degree in Electrical & Computer Engineering, Digital Signal Processing and Computer emphasis, with a Mathematics minor from Brigham Young University. He attended BYU on academic and Division 1 swimming scholarships, where he was team captain 2 years.
I have written 2 dutch books on value investing: "Aandelen selecteren als waardebelegger" and "Beleggen in bull- en bearmarkten". See bol.com (search for the titles).
As a mathematician (Ph.D.) I am most interested in investment strategies with statistically favorable returns. In particular I invest in net-nets (20-30% average annual returns). I find companies with low Enterprise Value/Earnings before Tax and Interest (EV/EBIT) and strong balance sheets (20% average annual returns) also very interesting. Since such stocks are rare I invest globally.
Click "Learn more" below to see my exclusive research description on net-nets and low EV/EBIT stocks.
Investment professional and CFA charterholder. I write on Seeking Alpha as a personal hobby and to elicit feedback on specific ideas and topics, help organize my thinking, and connect with intelligent people.
My life was changed when I read Ben Graham's "The Intelligent Investor". Buying low and selling high, what could be more logical? Hedge your bet by including a margin for error(ie. margin of safety). Yeah my transformation to a value and contrarian investor started with that book. Current member of StockBuz (stockbuz.net), a trading and investing oriented social network. On market days I can often be found in the chat room there, doing my best to annoy the technical analysis practitioners and day traders by pontificating the virtues of value investing.
Hospital based interventional radiologist located in New London, CT. with special interest in event driven investing and biotechnology companies with breakthrough therapies.
Sheldon Robbins, M.D.
Lawrence and Memorial Hospital
Dept. of Radiology
365 Montauk Ave.
New London, CT 06320
I am an experienced individual investor who has been trading merger arbitrage stocks and options since the 90's. I am a writer with a Master of Science from Northwestern University and I truly enjoy writing articles about the stock market. I try to look for opportunities where the odds are in my favor and there is a definite edge. On Seeking Alpha my articles will aim to provide insight and favorable risk/reward for the readers.However, I am not an investment advisor so any recomendations or ideas I write about in my articles, blogs, or comments shouldn't be taken as investment advice. I recommend using my writings as a starting point to which you should add your own research or that of an investment advisor.
"Any time you make a bet with the best of it, where the odds are in your favor, you have earned something on that bet, whether you actually win or lose the bet. By the same token, when you make a bet with the worst of it, where the odds are not in your favor, you have lost something, whether you actually win or lose the bet."
-David Sklansky, "The Theory of Poker"
Alumni of Indian Institute of Technology, Madras (Bachelors in Chem. Eng) , University of Cincinnati (Masters in Environmental Eng.) and MBA from University of Chicago Booth School of Business (concentrations in Strategy, Economics, Marketing).
Experience working as software consultant, project manager, utility senior engineer, entrepreneur. Areas of expertise include cloud databases, SCADA systems, water treatment, industrial waste water treatment, sensor technology and medical device development,
Currently CEO of a company that makes medical devices.
Dean, School of Business and Professor of Marketing at The College of New Jersey. Co-author with Peter Vander Nat, a senior economist at the FTC, of 2002 and 2014 journal articles on pyramid schemes and multilevel marketing. Also served as an expert witness in the prosecution of pyramid schemes, including Gold Unlimited, brought by the US Department of Justice, and International Heritage Inc, at the time the largest pyramid scheme prosecuted by the SEC.